Jennifer Lynne Fox insider trades

Open-market stock purchases and sales by Jennifer Lynne Fox, Chief Legal Officer at Myriad Genetics Inc, from SEC Form 4 filings since Mar 1, 2022.

Recent trades

DateStockTradeValue
Sep 3, 2026MYGN Myriad Genetics IncSold (not open market)$14.2K
Mar 13, 2026MYGN Myriad Genetics IncSold (not open market)$27.9K
Mar 12, 2026MYGN Myriad Genetics IncBought (not open market)—

Companies traded

  • MYGN Myriad Genetics Inc: other filings, last Sep 3, 2026
  • EBS Emergent BioSolutions Inc: other filings, last Jul 11, 2024

Get free alerts when Jennifer Lynne Fox files a new trade →